| 1 |
Executive Summary |
| 1.1 |
Main Findings |
| 1.2 |
Main Conclusions |
| 1.3 |
Bio-Detection Market Forecast 2011-2016 |
| 1.3.1 |
Overview |
| 1.3.2 |
Systems and Service & Upgrade Markets 2011-2016 |
| 1.3.3 |
Systems & Service Market by Modality 2011-2016 |
| 1.3.4 |
Systems & Service Market by Technology Generation 2011-2016 |
| 1.4 |
Bio-Detection Next Generation Business Opportunities |
| 1.5 |
Technologies Outlook |
| 2 |
Introduction |
| 2.1 |
Scope |
| 2.2 |
Methodology |
| 2.2.1 |
Research Methods |
| 2.2.2 |
Report Structure |
| 2.2.3 |
Assumptions |
| 2.3 |
Who is This Report For? |
| 3 |
Bio-Detection Market Drivers |
| 4 |
Bio-Detection Market Inhibitors |
| 5 |
Bio-Detection Industry Competitive Analysis |
| 6 |
Bio-Detection Industry SWOT Analysis |
| 7 |
Bio-detection Market Dynamics |
| 8 |
Defending Against Bioterrorism |
| 8.1 |
Definition of Bioterrorism |
| 8.2 |
The Threat of Bioterrorism |
| 8.3 |
How Real Is The Bioterrorism Threat? |
| 8.4 |
Bio-Defense Programs |
| 8.4.1 |
Strategy |
| 8.4.2 |
Project BioWatch |
| 8.4.3 |
Project BioSense |
| 8.4.4 |
Project BioShield |
| 8.5 |
Bio-Detection The Industry |
| 9 |
The Obama Administration Bio Terror Mitigation Strategy |
| 9.1 |
Biosurveillance Network |
| 9.2 |
Bio-Defense Funding |
| 9.2.1 |
Overview |
| 9.2.2 |
DHHS Bio-Defense Missions and Funding |
| 9.2.3 |
DHS Bio-Defense Missions and Funding |
| 9.2.4 |
DOD Bio-Defense Missions and Funding |
| 9.2.5 |
DOA Bio-Defense Missions and Funding |
| 9.2.6 |
EPA Bio-Defense Missions and Funding |
| 9.3 |
The Obama Administration Bio-Defense Strategy |
| 10 |
Bio-Detection Technologies Overview |
| 10.1 |
Bio-Detection Technology Challenges |
| 10.1.1 |
Sampling the Environment |
| 10.2 |
The Bio-Detection Process |
| 10.2.1 |
Bio-Detectors in a Multitude of Ambient Settings |
| 10.2.2 |
Bio-Detection Triggering |
| 10.2.3 |
Collection of Particles |
| 10.2.4 |
Bio-Particle Detectors |
| 10.2.5 |
Bio-Agent Identification |
| 11 |
Major Bio-Detection Technological Challenges |
| 11.1 |
Challenge 1 Detection of Small Particle Concentration |
| 11.2 |
Challenge 2 Eliminating Bio Background |
| 11.3 |
Challenge 3 Expensive Reagents |
| 11.4 |
Challenge 4 Expensive Equipment Maintenance |
| 11.5 |
Challenge 5 Adapting Equipment to Changing Environments |
| 11.6 |
Challenge 6 Dealing With Emerging Threats |
| 12 |
Bio Detection Technologies Review & Outlook 2011-2016 |
| 12.1 |
Bio-Detection Core Technologies Comparison |
| 12.2 |
Collector/Concentrator Core Technologies |
| 12.3 |
Cyclone Collectors |
| 12.4 |
Variable Particle-Size Impactor |
| 12.5 |
Virtual Impactors |
| 12.6 |
Impingers |
| 12.7 |
Reagentless Trigger Core Technologies |
| 12.7.1 |
Flow Cytometry |
| 12.7.2 |
Particle Sizing |
| 12.7.3 |
Gas Chromatography |
| 12.7.4 |
Trigger Technologies Drivers |
| 12.7.5 |
Trigger Technologies Inhibitors |
| 12.8 |
DNA Based Diagnostic Core Technologies |
| 12.8.1 |
Overview of DNA-Based Detection |
| 12.8.2 |
Polymerase Chain Reaction (PCR) |
| 12.8.3 |
DNA / RNA Microarrays |
| 12.8.4 |
DNA Technology Drivers |
| 12.8.5 |
DNA Technology Inhibitors |
| 12.9 |
Antibody-Antigen Diagnostic Core Technologies |
| 12.9.1 |
Overview of Antibody-Antigen Reaction |
| 12.9.2 |
Hand-Held Immuno-Chromatographic Assays (HHA) |
| 12.9.3 |
Magnetic Microbead-Base Assays |
| 12.9.4 |
Microfluidic Devices “Lab on a Chip” |
| 12.9.5 |
Fluorescence Imaging |
| 12.9.6 |
Electrochemical-Luminescence (ECL) |
| 12.9.7 |
Antibody/Antigen Technology Drivers |
| 12.9.8 |
Antibody/Antigen Technology Inhibitors |
| 12.1 |
Signal Analysis Algorithms |
| 12.10.1 |
Clustering / Classifier Algorithms |
| 12.10.2 |
Image Analysis Algorithms |
| 12.10.3 |
Decision Algorithms |
| 12.10.4 |
Algorithm Drivers |
| 12.10.5 |
Algorithm Inhibitors |
| 12.11 |
Rapid Microbiological Technologies |
| 13 |
Biological Detection Overview by Application |
| 13.1.1 |
Application 1 Emergency Responder Hand-Held Detectors |
| 13.1.2 |
Application 2 Emergency Responder Mobile Labs |
| 13.1.3 |
Application 3 Indoor Standoff Detectors |
| 13.1.4 |
Application 4 Outdoor Standoff Detectors |
| 14 |
U.S. Bio-Detection Systems Market Outlook 2011-2016 |
| 14.1 |
Methodology |
| 14.2 |
Bio-Detection Systems Sales 2011-2016 |
| 14.2.1 |
Bio-Detection Systems Revenue Sales by Generation Forecast 2011-2016 |
| 14.2.2 |
Bio-Detection Systems Sales by Modality 2011-2016 |
| 14.3 |
Bio-Detection Systems Quantity Sales 2011-2016 |
| 14.3.1 |
Bio-Detection Systems Quantity Sales by Generation 2011-2016 |
| 14.3.2 |
Bio-Detection Systems Quantity Sales by Modality 2011-2016 |
| 14.4 |
Outdoor Bio-Detection Systems Market 2011-2016 |
| 14.4.1 |
Outdoor Standoff Detection Systems Revenue Sales Outlook 2011-2016 |
| 14.4.2 |
Outdoor Standoff Detection Systems Quantity Sales Outlook 2011-2016 |
| 14.5 |
Indoor Bio-Detection Systems Market 2011-2016 |
| 14.5.1 |
Indoor Standoff Systems Detection Sales 2011-2016 |
| 14.5.2 |
Indoor Standoff Systems Unit Sales 2011-2016 |
| 14.6 |
First Responder Hand-Held Bio-Detection Systems Market 2011-2016 |
| 14.6.1 |
First Responder Hand-Held Systems Sales 2011-2016 |
| 14.6.2 |
First Responder Hand-Held Systems Quantity Sales 2011-2016 |
| 14.7 |
Mobile Bio-Detection Labs Market 2011-2016 |
| 14.7.1 |
First Responder Mobile Labs Sales 2011-2016 |
| 14.7.2 |
First Responder Mobile Labs Quantity Sales 2011-2016 |
| 15 |
Service & Upgrade Business 2011-2016 |
| 15.1 |
Bio-Detection Service & Upgrade Business by Modality 2011-2016 |
| 15.2 |
Bio-Detection Service Business by Technology Generation 2011-2016 |
| 16 |
Business Opportunities in Bio-Detection 2011-2016 |
| 16.1 |
Historical Perspective |
| 16.1.1 |
A Market Waiting for Transition |
| 16.1.2 |
The Current and Future HLS Bio-Defense Strategy for Detection |
| 16.1.3 |
Factors Affecting Biological Detectors Deployment and Technologies 2011-2016 |
| 16.1.4 |
Biological Detection Technology Timeline |
| 16.2 |
Next Generation HLS Bio-Detection Systems Business Opportunities |
| 16.2.1 |
Overview |
| 16.2.2 |
Business Opportunity 1 Emerging Threats |
| 16.2.3 |
Business Opportunity 2 Human Sentinel Surveillance System |
| 16.2.4 |
Business Opportunity 3 Animal Sentinel Surveillance System |
| 16.2.5 |
Business Opportunity 4 Biological IC3 Biological Threat Assessment Intelligence Command, Control, and Communication Infrastructure |
| 16.2.6 |
Business Opportunity 5 Reducing False Alarms Lesser False Positives and False Negatives |
| 16.2.7 |
Business Opportunity 6 Reducing Cost Minimizing Use of Non-Reusable Reagents |
| 16.3 |
Outdoor Standoff Biological Detectors |
| 16.3.1 |
Business Opportunity 7 Bioagent Autonomous Networked Detectors (BAND) |
| 16.3.2 |
Business Opportunity 8 Rapid Automated Biological Identification System (RABIS) |
| 16.3.3 |
Business Opportunity 9 First Responder Portable Hand-Held Detector |
| 16.3.4 |
Business Opportunity 10 First Responder Mobile Biological Detection Station |
| 16.3.5 |
Business Opportunity 11 Regional Automatic Detector Outdoor Standoff Detectors |
| 16.3.6 |
Business Opportunity 12 Networked Automatic Detector Indoor Standoff Detectors |
| 16.3.7 |
Business Opportunity 13 External Spread of Bioagent Detection |
| 16.3.8 |
Business Opportunity 14 Internal Spread of Bioagent |
| 16.4 |
Other Bio-Detection Technologies Business Opportunities |
| 16.4.1 |
Business Opportunity 15 “Lab on a Chip” Miniature Detection Devices |
| 16.4.2 |
Business Opportunity 16 Reagentless Specific Detection Assays |
| 16.4.3 |
Business Opportunity 17 Laser Induced Breakdown Spectroscopy (LIBS) |
| 16.4.4 |
Business Opportunity 18 Raman Spectroscopy-based Reagentless Detection |
| 16.5 |
Future Technologies and Systems |
| 17 |
Bio-Detection Personnel Considerations |
| 17.1 |
Background Personnel |
| 17.2 |
Personnel Training |
| 18 |
Vendors |
| 18.1 |
20/20 GeneSystems Inc. |
| 18.2 |
Advnt Biotechnologies |
| 18.3 |
Agilent Technologies |
| 18.4 |
Alexeter Technologies |
| 18.5 |
ANP Technologies, Inc. |
| 18.6 |
BAS – Biological Alarm Systems Ltd. (Israel) |
| 18.7 |
BD Biosciences Immunocytometry Systems |
| 18.8 |
Bertin Technologies |
| 18.9 |
BioDefense Corporation |
| 18.1 |
BioDETECT AS |
| 18.11 |
BioSentinel Pharmaceuticals LLC |
| 18.12 |
3M Microbiology (Biotrace International, Ltd.) |
| 18.13 |
BioTraces, Inc. |
| 18.14 |
BioVeris Corporation |
| 18.15 |
Biral |
| 18.16 |
Cepheid |
| 18.17 |
Commonwealth Biotechnologies, Inc. |
| 18.18 |
Dycor Technologies Ltd. |
| 18.19 |
Environics Oy |
| 18.2 |
Evogen, Inc. |
| 18.21 |
General Dynamics Canada |
| 18.22 |
GenPrime, Inc. |
| 18.23 |
Groton Biosystems |
| 18.24 |
Haztech Systems, Inc. |
| 18.25 |
Idaho Technology, Inc. |
| 18.26 |
JMAR Technologies, Inc. |
| 18.27 |
New Horizons Diagnostics |
| 18.28 |
Proengin |
| 18.29 |
QTL Biodetection |
| 18.3 |
Research International |
| 18.31 |
Response Biomedical |
| 18.32 |
Roche Applied Science |
| 18.33 |
Smiths Detection |
| 18.34 |
Tetracore, Inc. |
| 19 |
Prices of Bio-Detection Equipment |
| 20 |
Appendix A: The Threat of Bioweapons |
| 20.1 |
Use of Bioweapons Historical Perspective |
| 20.2 |
Biological Terror Bacterial Agents |
| 20.2.1 |
Anthrax |
| 20.2.2 |
Cholera |
| 20.2.3 |
Plague |
| 20.2.4 |
Tularemia |
| 20.3 |
Biological Terror Viral Agents |
| 20.3.1 |
Smallpox |
| 20.3.2 |
Hemorrhagic Fever Viruses |
| 20.3.3 |
Venezuelan Equine Encephalitis |
| 20.4 |
Biological Terror Rickettsiae Agents |
| 20.4.1 |
Q Fever |
| 20.4.2 |
Typhus |
| 20.5 |
Biological Terror Toxins |
| 20.5.1 |
Botulinum Toxin |
| 20.5.2 |
Ricin |
| 20.5.3 |
Saxitoxin |
| 20.5.4 |
Staphylococcal Enterotoxin B (SEB) |
| 21 |
Appendix B: Legal Issues |
| 21.1 |
International / European Legislation / Agreements |
| 21.1.1 |
The Biological and Toxin Weapons Convention (BTWC) 1972 |
| 21.2 |
U.S. Bioterrorism Legislation |